Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026)

Zai Lab (ZLAB) posted Total Current Liabilities of $393.0 million for Q1 2026, down 5.57% sequentially from $416.2 million in Q4 2025, and up 22.88% YoY from $319.8 million in Q1 2025.

Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026) Analysis & Trends

Zai Lab has reported Total Current Liabilities for 11 years, with the latest figure at $393.0 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 22.88% year-over-year to $393.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $393.0 million (up 22.88% YoY) and the FY2025 annual result came in at $416.2 million, up 39.01% from the prior year.
  • Total Current Liabilities eased to $393.0 million in Q1 2026 per ZLAB's latest filing, from $416.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $416.2 million in Q4 2025 and troughed at $124.6 million in Q1 2023.
  • A 5-year average of $238.5 million and a median of $203.1 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2024: Total Current Liabilities declined 27.51% in 2022, then jumped 129.24% in 2024.
  • Over 5 years, Total Current Liabilities stood at $139.8 million in 2022, then surged by 45.21% to $203.1 million in 2023, then jumped by 47.43% to $299.4 million in 2024, then soared by 39.01% to $416.2 million in 2025, then decreased by 5.57% to $393.0 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $393.0 million, $416.2 million, and $359.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 428.58 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 428.58 Mn
Mar 31, 2026 392.98 Mn
Dec 31, 2025 416.17 Mn
Sep 30, 2025 359.77 Mn
Jun 30, 2025 331.50 Mn
Mar 31, 2025 319.81 Mn
Dec 31, 2024 299.39 Mn
Sep 30, 2024 286.32 Mn
Jun 30, 2024 251.72 Mn
Mar 31, 2024 192.11 Mn
Dec 31, 2023 203.07 Mn
Sep 30, 2023 124.90 Mn
Jun 30, 2023 133.35 Mn
Mar 31, 2023 124.56 Mn
Dec 31, 2022 139.84 Mn
Sep 30, 2022 155.55 Mn
Jun 30, 2022 168.88 Mn
Mar 31, 2022 154.91 Mn
Dec 31, 2021 192.90 Mn
Sep 30, 2021 112.01 Mn